Luvo Health Review

The current Luvo homepage, medication catalog, pricing table, FAQ, terms, refund policy, privacy policy, telehealth consent, official logo assets, LegitScript badge link, FDA compounding materials, production AllyRx catalog, and internal affiliate record were checked. No intake, account, patient lead, prescription request, payment, or production data was submitted.

Luvo Health, Inc. is the legal platform operator named in the terms. Luvo says it supplies administrative, coordination, and technology services rather than medical care. Independent clinical partners, which may include OpenLoop Healthcare Partners and affiliated professional entities, evaluate patients and make prescribing decisions.

Telehealth can include an online intake, secure messages, audio, or video. The assigned clinician decides whether remote care is appropriate and may require more information, laboratory work, or a live visit. Completing intake does not guarantee a match, consultation, prescription, medication, dose, or treatment plan.

Luvo advertises an average clinical review time of 24 hours, service in 50 states, and more than 20 medications. The terms extend the geographic claim to all 50 states and Washington, D.C., while warning that a particular service can still be limited by law, licensing, clinician availability, medication availability, or pharmacy coverage.

The current catalog has 35 product pages across weight loss, microdosing, longevity, skincare, women's hormone care, and men's testosterone care. This draft does not turn every page into a therapy. It consolidates active ingredients and routes, and it separates standard-dose programs from the lower-dose microdosing offers.

The standard weight-management offers are compounded semaglutide injection, compounded tirzepatide injection, and compounded oral semaglutide tablets. The injection pages describe weekly subcutaneous use. The tablet page describes daily oral use. Exact concentration, additives, supplied quantity, and patient-specific titration are not published.

Ozempic and Zepbound also have product pages and one four-week price each: $1,299 and $1,399. Ozempic contains semaglutide and is not approved specifically for chronic weight management, while Zepbound contains tirzepatide and is approved for chronic weight management in eligible adults. Luvo says branded prescriptions can be transferred to a retail or mail-order pharmacy, where the pharmacy controls the price and a coordination fee may apply.

Luvo's microdosing pages use the same semaglutide and tirzepatide active ingredients at clinician-guided doses below standard weight-loss dosing. Those are dosage strategies, not new medications. Their four- and twelve-week totals are $179 and $507, but they are not blended into the full-dose averages.

Longevity pages cover sermorelin acetate and NAD+ as an injection, sublingual drops, or nasal spray. Each NAD+ route uses the same published term totals, so the review consolidates the ingredient into one card and preserves the routes in its notes. Vitamin B12/MIC stays editorial-only because the page says the MIC blend and B12 form may vary by pharmacy and plan.

The men's hormone catalog includes a testosterone injection, enclomiphene tablets, and gonadorelin injection. The testosterone page does not identify the ester, concentration, vial quantity, or exact route for an individual prescription, so it is not mapped to testosterone cypionate. Enclomiphene is mapped by active ingredient, with a note that anastrozole may be added when clinically indicated.

Women's care includes estradiol tablets, cream, patch, vaginal gel, and vaginal tablet. It also includes testosterone injection, tablet, and gel plus non-hormonal paroxetine and desvenlafaxine options. The draft consolidates estradiol into one editorial-only card and leaves the other route and symptom-treatment choices in the narrative rather than multiplying medication records.

The branded skincare names resolve into eight multi-ingredient creams. The two anti-aging formulas contain either estriol with sodium hyaluronate and vitamin C, or tretinoin with niacinamide and sodium hyaluronate. The acne formulas contain tretinoin with niacinamide, or topical spironolactone with niacinamide.

The rosacea formulas contain azelaic acid, metronidazole, and ivermectin, or niacinamide, ivermectin, and a lower metronidazole concentration. The tone formulas contain hydroquinone, tretinoin, kojic acid, niacinamide, and fluocinolone, or azelaic acid with niacinamide. None is collapsed into a single-ingredient comparison card.

The pricing page lists four-, twelve-, twenty-four-, and fifty-two-week totals for several products. Longer selections produce lower effective rates. The page also says price can depend on treatment plan, medication, and dose, so the draft does not assume that every patient or dose receives the displayed amount.

The card averages convert every week-based term to a calendar-month equivalent using 52 weeks per year and 12 months per year. The unweighted mean of those plan-level rates is $229.13 for compounded semaglutide injection, $326.63 for compounded tirzepatide injection, $267.04 for oral semaglutide, $169.54 for sermorelin, $169.54 for each NAD+ route, $150.81 for men's testosterone injection, and $172.06 for enclomiphene.

The source HTML currently contains a $10/week placeholder for every product's weekly display field, even when the product page and term totals imply a different rate. The review ignores that placeholder and reconstructs every compact price from the published term totals.

A plan price may bundle platform access, clinical services, medication, pharmacy services, shipping, laboratory work, and support, but the exact included components vary by plan and medical eligibility. The final checkout and account record control the selected charge, renewal timing, and inclusions.

Many plans operate as subscriptions. The terms say renewal timing and pricing appear during enrollment or in the account. Charges and shipments may process up to two days before the nominal renewal date, including around weekends and holidays.

Cancellation is available through the account or support@luvohealth.com. The request must arrive at least 72 hours before the renewal or renewal-processing date to prevent the next charge. Access continues through the current paid cycle, and cancellation does not create a retroactive refund.

The refund policy says the subscription starts and the first charge occurs when intake is completed. A patient whom a clinician disqualifies for a medical reason before medication is ordered receives a full refund. Otherwise, current-cycle refunds generally require cancellation before a prescription is issued and sent to the pharmacy.

For a new asynchronous patient, the policy generally considers medication ordered when intake is submitted. If a video visit is required, it generally considers the order placed when that visit is completed. Clinical consultations and medical reviews are nonrefundable once rendered, regardless of fulfillment.

Only the most recent billing cycle is eligible for a refund. A bundled or multi-month refund is prorated using the standard non-bundled monthly retail price and the number of shipments already received. Damaged or incorrect medication is usually replaced after verification, while a refund remains case-specific.

The terms name Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine, and Triad Rx. The assigned pharmacy is disclosed in order confirmation and shipping documents and may change. Luvo also says patients may request an outside licensed pharmacy, although compounded prescriptions may not be practical to transfer and a coordination fee may apply.

Luvo promises discreet packaging and tracking after shipment. Temperature-sensitive medication uses insulated packaging and temperature controls when needed. No universal processing or delivery window is published, and replacement options for a carrier-marked delivery or temperature problem depend on the facts.

Administrative support is available at support@luvohealth.com, and account messaging is the stated route for non-urgent clinical questions. Public pages do not list support hours, a general telephone number, a response-time target, or separate escalation standards for billing, pharmacy, clinical, and shipment problems.

Luvo's privacy policy says the platform itself is not a HIPAA covered entity. Information collected by Luvo through onboarding, support, marketing tools, and payment flows is governed by its privacy policy, while clinical partners may have separate HIPAA duties and notices. Luvo says it does not sell personal information or identifiable consumer health data.

Compounded products are not FDA approved and do not receive FDA premarket review for safety, effectiveness, or quality. FDA says compounded GLP-1 products should be patient-specific and has warned about storage, fraudulent labeling, salt forms, dose measurement, and rapid-titration problems. FDA also says semaglutide and tirzepatide are not currently on its drug shortage list.

BPC-157 appears only as Coming Soon and has no active price or treatment path, so it is excluded. Luvo refers to a recent advisory committee recommendation, but an advisory vote is nonbinding and does not itself add a substance to the federal bulks list. Availability must be rechecked if Luvo activates the page.

The official site displays a LegitScript seal linked to LegitScript's domain checker. The accessible checker page did not expose a result in the research session, so the draft records the displayed badge but does not independently claim certification status.

The strongest features are treatment breadth, exact term totals for many products, clinician-controlled eligibility, named pharmacies, and clear cancellation and refund documents. The main limitations are dose and formula opacity, four-week billing, incomplete plan rows, early renewal processing, narrow refund timing, and limited public support and delivery commitments.